Ontario Invests $1.7 Million in Piramal Pharma’s Aurora Facility
The project will create 12 jobs and protect 183 positions while expanding Ontario-made health technologies and domestic API production.
- On Wednesday, September 30, 2026, the Ontario government announced a $1,753,620 investment in Piramal Pharma Solutions' Aurora facility through the Life Sciences Scale-Up Fund to upgrade infrastructure and commercialize health technologies.
- Piramal Pharma Solutions is investing over $5.3 million to upgrade site infrastructure, strengthening Ontario's pharmaceutical manufacturing sector and bolstering domestic production of APIs.
- The project will create 12 new jobs and protect 183 existing positions while enhancing R&D and clinical API production at the Aurora site.
- MPP Dawn Gallagher Murphy said the investment positions Piramal to "turn their latest ideas into market-ready solutions," reinforcing Ontario's role as a global life sciences hub.
- Launched in 2024, the $24 million LSSUF works in tandem with the government's Health Innovation Pathway to advance Phase 2 of Ontario's Life Sciences Strategy and strengthen health innovation.
14 Articles
14 Articles
NiagaraFallsReview.ca
Aurora’s Piramal Pharma receives $1.7 million to further life sciences innovation
One-hundred-and-ninety-five local jobs will be supported through a $1.7 million Provincial investment in the Aurora-based Piramal Pharma Solutions.
Ont. Government Invests $1.7M In Piramal Pharma Solutions' Aurora, Ont. Facility
MUMBAI — Piramal Pharma Solutions (PPS), a Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd., announced that its Aurora, Canada drug substance site has received a $1,753,620 investment from the Ontario government through the Life Sciences Scale-Up Fund (LSSUF), enabling PPS to upgrade site infrastructure and commercialize Ontario-made health technologies for new markets. With support from the government o…
Tribune India
The WireOntario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharmas Aurora Facility
• Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. • With its investment through the Life Sciences Scale-Up Fund, the Ontario government is supporting healthcare innovation and reinforcing its province's...
Coverage Details
Bias Distribution
- 42% of the sources lean Left, 42% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
